We’re excited that Huanyi Chen, CEO of MaH, will be attending BIOCHINA 2025 from March 13-15 in Suzhou International Expo Center!
As Asia’s premier biotech event, BIOCHINA gathers 30,000+ global experts to drive innovation in antibody drugs, synthetic biology, cell & gene therapy, and more. Meet industry leaders from BeiGene, Henlius, TopAlliance, WuXi Biologics, and beyond.
🔬 Why Attend?
✅ Drug Licensing – Discover pre-clinical, clinical, and listed drugs
✅ Supply Chain – Connect with 500+ suppliers
✅ Product Promotion – Reach 3,000+ biotech firms in China
✅ Funding & Partnerships– Meet investors & explore new collaborations
With 750+ speakers, 180+ sessions, and 1,000+ BiOPartnering meetings, this is an unmissable event!
See you at BIOCHINA 2025!🇨🇳